U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C15H18O3S
Molecular Weight 278.367
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of GUALENIC ACID

SMILES

CC(C)C1=CC=C(C)C2=C(C=C(C)C2=C1)S(O)(=O)=O

InChI

InChIKey=VIZXMHCBZLGUET-UHFFFAOYSA-N
InChI=1S/C15H18O3S/c1-9(2)12-6-5-10(3)15-13(8-12)11(4)7-14(15)19(16,17)18/h5-9H,1-4H3,(H,16,17,18)

HIDE SMILES / InChI

Description
Curator's Comment: description was created based on several sources, including http://aksci.com/item_detail.php?cat=R239 http://www.ncbi.nlm.nih.gov/pubmed/15667596

Sodium gualenate (Azunol ST Tablets) is a water-soluble derivative of azulene, a natural product which is an antiinflammatory component of chamomile of the family of Asteraceae. Sodium gualenate was originally studied as an antiulcer agent, is primary indicated in conditions like Duodenal ulcer, Gastric ulcer, Gastritis, but it is also clinically used as a therapeutic agent in the treatment of inflammation of the mouth and throat, for example, pharyngitis as well as other inflammatory diseases such as tonsillitis, stomatitis and conjunctivitis. Although the mechanism by which sodium azulene sulfonate inhibited the capsaicin-induced pharyngitis is not yet unraveled, antioxidative effect, but not inhibitory effect on cyclooxygenase pathway, might be involved.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
[Preventive effects of oren-gedoku-to on mucositis caused by anticancer agents in patients with acute leukemia].
2003 Sep
The molecular immunology of mucositis: implications for evidence-based research in alternative and complementary palliative treatments.
2005 Dec
Patents

Patents

Sample Use Guides

Put 1 tablet (5 mg of the active ingredient) between either of right or left upper lip and gum at a time, four times daily.
Route of Administration: Oral
In Vitro Use Guide
Unknown
Name Type Language
GUALENIC ACID
WHO-DD  
Common Name English
1-AZULENESULFONIC ACID, 3,8-DIMETHYL-5-(1-METHYLETHYL)-
Common Name English
5-ISOPROPYL-3,8-DIMETHYLAZULENE-1-SULFONIC ACID
Systematic Name English
Gualenic acid [WHO-DD]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C257
Created by admin on Fri Dec 15 15:56:28 GMT 2023 , Edited by admin on Fri Dec 15 15:56:28 GMT 2023
Code System Code Type Description
NCI_THESAURUS
C80555
Created by admin on Fri Dec 15 15:56:28 GMT 2023 , Edited by admin on Fri Dec 15 15:56:28 GMT 2023
PRIMARY
EPA CompTox
DTXSID10168665
Created by admin on Fri Dec 15 15:56:28 GMT 2023 , Edited by admin on Fri Dec 15 15:56:28 GMT 2023
PRIMARY
FDA UNII
GR01836V0K
Created by admin on Fri Dec 15 15:56:28 GMT 2023 , Edited by admin on Fri Dec 15 15:56:28 GMT 2023
PRIMARY
PUBCHEM
2275
Created by admin on Fri Dec 15 15:56:28 GMT 2023 , Edited by admin on Fri Dec 15 15:56:28 GMT 2023
PRIMARY
SMS_ID
100000086674
Created by admin on Fri Dec 15 15:56:28 GMT 2023 , Edited by admin on Fri Dec 15 15:56:28 GMT 2023
PRIMARY
EVMPD
SUB02421MIG
Created by admin on Fri Dec 15 15:56:28 GMT 2023 , Edited by admin on Fri Dec 15 15:56:28 GMT 2023
PRIMARY
CAS
16915-32-5
Created by admin on Fri Dec 15 15:56:28 GMT 2023 , Edited by admin on Fri Dec 15 15:56:28 GMT 2023
PRIMARY